These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 11273729

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. PKC-dependent delayed metabolic preconditioning is independent of transient MAPK activation.
    Mockridge JW, Punn A, Latchman DS, Marber MS, Heads RJ.
    Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H492-501. PubMed ID: 10924046
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
    Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL.
    Circulation; 1999 Apr 06; 99(13):1685-91. PubMed ID: 10190877
    [Abstract] [Full Text] [Related]

  • 25. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S, Tosaki A, Bagchi D, Maulik N, Das DK.
    J Pharmacol Exp Ther; 2006 Jun 06; 317(3):980-8. PubMed ID: 16525036
    [Abstract] [Full Text] [Related]

  • 26. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning.
    Zhang Y, Gu EW, Zhang J, Chen ZW.
    Chin Med J (Engl); 2007 May 05; 120(9):777-81. PubMed ID: 17531118
    [Abstract] [Full Text] [Related]

  • 27. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.
    Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, Marber MS.
    FASEB J; 2000 Nov 05; 14(14):2237-46. PubMed ID: 11053245
    [Abstract] [Full Text] [Related]

  • 28. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.
    Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, Schlack W.
    Br J Pharmacol; 2005 Jan 05; 144(1):123-32. PubMed ID: 15644876
    [Abstract] [Full Text] [Related]

  • 29. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.
    Tanno M, Gorog DA, Bellahcene M, Cao X, Quinlan RA, Marber MS.
    J Mol Cell Cardiol; 2003 Dec 05; 35(12):1523-7. PubMed ID: 14654378
    [Abstract] [Full Text] [Related]

  • 30. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
    Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M.
    Circ Res; 2001 Feb 02; 88(2):175-80. PubMed ID: 11157669
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
    Barancik M, Htun P, Strohm C, Kilian S, Schaper W.
    J Cardiovasc Pharmacol; 2000 Mar 02; 35(3):474-83. PubMed ID: 10710135
    [Abstract] [Full Text] [Related]

  • 32. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
    Lochner A, Genade S, Moolman JA.
    Basic Res Cardiol; 2003 Sep 02; 98(5):337-46. PubMed ID: 12955407
    [Abstract] [Full Text] [Related]

  • 33. Involvement of p38 MAPK and JNK in heat stress-induced cardioprotection.
    Pantos C, Malliopoulou V, Mourouzis I, Moraitis P, Tzeis S, Thempeyioti A, Paizis I, Cokkinos A, Carageorgiou H, Varonos DD, Cokkinos DV.
    Basic Res Cardiol; 2003 May 02; 98(3):158-64. PubMed ID: 12883833
    [Abstract] [Full Text] [Related]

  • 34. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning.
    Pantos CI, Malliopoulou VA, Mourouzis IS, Karamanoli EP, Paizis IA, Steimberg N, Varonos DD, Cokkinos DV.
    Thyroid; 2002 Apr 02; 12(4):325-9. PubMed ID: 12034058
    [Abstract] [Full Text] [Related]

  • 35. Dual effects of dichloroacetate on cardiac ischaemic preconditioning in the rat isolated perfused heart.
    Randall MD, Keon CA, Greenhaff PL, Constantin-Teodosiu D.
    Br J Pharmacol; 1998 May 02; 124(1):245-51. PubMed ID: 9630366
    [Abstract] [Full Text] [Related]

  • 36. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, Martin JL, Davis RJ, Flavell RA, Marber MS.
    Circ Res; 2003 Aug 08; 93(3):254-61. PubMed ID: 12829618
    [Abstract] [Full Text] [Related]

  • 37. SAPKs regulation of ischemic preconditioning.
    Sato M, Cordis GA, Maulik N, Das DK.
    Am J Physiol Heart Circ Physiol; 2000 Sep 08; 279(3):H901-7. PubMed ID: 10993748
    [Abstract] [Full Text] [Related]

  • 38. p38 MAP kinase is a mediator of ischemic preconditioning in pigs.
    Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G.
    Cardiovasc Res; 2002 Aug 15; 55(3):690-700. PubMed ID: 12160966
    [Abstract] [Full Text] [Related]

  • 39. Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury.
    Rakhit RD, Kabir AN, Mockridge JW, Saurin A, Marber MS.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):995-1002. PubMed ID: 11527399
    [Abstract] [Full Text] [Related]

  • 40. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts.
    Suematsu Y, Ohtsuka T, Hirata Y, Maeda K, Imanaka K, Takamoto S.
    Eur J Cardiothorac Surg; 2001 Jun 07; 19(6):873-9. PubMed ID: 11404145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.